The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 75 institutes and research facilities of the Fraunhofer-Gesellschaft, the world's leading organization for application-oriented research. The goals of contract research at Fraunhofer ITEM are to protect people in our industrialized world from health hazards and to contribute to the development of new therapeutic approaches. With a focus on cardiac and pulmonary research, the R&D portfolio comprises three business units: Drug Development, Chemical Safety, and Translational Medical Technology. Our site in Regensburg also conducts research into personalized tumor therapy.
